Clinical trial
The Impact of Oral Bacteria on Lung Function and Inflammation
NCT04781153 is registered in ClinicalTrials.gov with Anders Røsland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Oral Bacteria on Lung Function and Inflammation
- Lead sponsor
- Anders Røsland
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2021
- Completion date
- June 27, 2024
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
airway obstruction, lung inflammation, periodontitis